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Translation shutoffs (PV), Coxsackie B virus (CVB) and rhinovirus (HRV) are members of Picorna-
viridae that inhibit host cell translation early in infection. Enterovirus translation soon predominates in
infected cells, but eventually also shuts off. This complex pattern of modulation of translation suggests
regulation by a multifactorial mechanism. We report here that eIF5B is proteolytically cleaved during PV and
CVB infection of cultured cells, beginning at 3 hours post-infection and increasing thereafter. Recombinant
PV, CVB and HRV 3Cpro cleaved puriﬁed native rabbit eukaryotic initiation factor (eIF) 5B in vitro at a single
site (VVEQ↓G, equivalent to VMEQ↓G479 in human eIF5B) that is consistent with the cleavage speciﬁcity of
enterovirus 3C proteases. Cleavage separates the N-terminal domain of eIF5B from its essential conserved
central GTPase and C-terminal domains. 3Cpro-mediated cleavage of eIF5B may thus play an accessory role in
the shutoff of translation that occurs in enterovirus-infected cells.
© 2008 Elsevier Inc. All rights reserved.IntroductionInfection byenteroviruses such as poliovirus (PV), Coxsackie B virus
(CVB) and human rhinovirus (HRV), members of the family Picorna-
viridae, leads to inhibition of host cell protein synthesis. During PV
infection, shutoff begins within 2h, is complete with 4h, and is
followed bya phase duringwhich viral translation is also progressively
inhibited (Etchison et al., 1982). The biphasic nature of these changes
suggests that shutoff occurs by a multifactorial mechanism, so that
factors required for translation of cellular mRNAs (predominantly
following cap-dependent initiation) are targeted during the ﬁrst phase
of shutoff and factors that are also required for translation of viral
mRNAs may be inactivated later. Enterovirus mRNAs all contain an
internal ribosomal entry site (IRES) that promotes initiation by cap-
independent ribosomal binding to the mRNA (Hellen and Sarnow,
2001), unlike most cellular mRNAs, which are translated following
cap-dependent initiation.
Whereas the mechanism of initiation on enterovirus IRESs is
incompletely characterized, many details of the cap-dependent
initiation mechanism have been elucidated (Pestova et al., 2007).
First, eIF1, eIF1A and eIF3 promote binding of eIF2·GTP·Met-tRNAMeti to
a 40S ribosomal subunit to form a 43S preinitiation complex. Itsogy and Immunology, SUNY
44, Brooklyn, NY 11203, USA.
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l rights reserved.attachment to the capped 5′ end of mRNA is mediated by eIF4F (which
consists of the eIF4E cap-binding subunit, the eIF4A RNA helicase and
eIF4G), and is enhanced by eIF4B and the poly(A) binding protein
(PABP). eIF4G coordinates ribosomal recruitment tomRNAs by binding
PABP,mRNA and eIFs 3, 4E and 4A. 43S complexes scan to the initiation
codon, forming 48S complexes inwhich theMet-tRNAMeti anticodon is
base-paired to the initiation codon in the ribosomal peptidyl (P) site. In
the ﬁnal subunit-joining stage, eIF5 induces hydrolysis of eIF2-bound
GTP, releasing Met-tRNAMeti into the P site, and eIF5B mediates
displacement of eIF2 GDP and other factors from the 48S complex and
joining of a 60S subunit to yield an 80S ribosome.
The earliest changes in the translation apparatus during enter-
ovirus infection involve cleavage by the virus-encoded 2A protease
(2Apro) of eIF4GI (whichprecedes the shutoff of host protein synthesis),
andwith slightly slowerkinetics, of the less abundant eIF4GII (Etchison
et al.,1982; Gradi et al.,1998). eIF4GI/eIF4GII are cleaved at a single site,
splitting domains that bind PABP and eIF4E from those that bind eIF3
and eIF4A (Lamphear et al., 2005), thereby abrogating eIF4G's function
in bridging factors that bind capped mRNA, that unwind mRNA and
that bind the ribosome. PABP is also cleaved in enterovirus-infected
cells, predominantly by the 3C protease (3Cpro), which separates PABP
into an N-terminal fragment that binds eIF4G and the 3′ poly(A) tail of
mRNA, and a C-terminal fragment that binds eIF4B and the termination
factor eRF3 (Joachims et al., 1999; Kerekatte et al., 1999; Kuyumcu-
Martinez et al., 2002). In addition, the translation regulator 4E-BP1
is dephosphorylated during infection. This event sequesters eIF4E
and abrogates eIF4F's cap-binding function, which contributes to the
Fig. 1. Cleavage of eIF5B during enterovirus infections. (A, B) 293 Tcellsweremock infected
(M) or infected with (A) poliovirus or (B) Coxsackievirus B3 (CVB3) and pulse labeled with
[35S]Trans label. Samples from mock-infected cells were pulse-labeled at 1 hour p.i. and
harvested at2hours p.i.; samples for infected cellswereharvested at the indicatedhours p.i.
after pulse-labeling for 1 h. Aliquots were then analyzed by SDS-PAGE. (C, D) Aliquots
of samples of mock-infected 293T (m) or 293T cells infected with (C) poliovirus and
(D) Coxsackievirus B3 and harvested at the indicated times (hours) p.i. were subjected to
SDS-PAGE and immunoblotted with a polyclonal antibodies to eIF5B. A ~70 kDa host
protein present in mock-infected cells that cross-reacted with these antibodies is in-
dicated by asterisks (⁎) and served as an internal loading control. The positions of
molecular weight markers, of intact eIF5B and of a cleavage product (cp) are indicated.
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translation (Gingras et al., 1996; Svitkin et al., 2005), but cannot fully
account for shutoff because it lags behind this process.
To obtain a more complete overview of the shut-off process, the
status in PV and CVB type 3 (CVB3)-infected cells of factors involved in
subunit joiningwas analyzed. eIF5Bwas found to be cleaved at a single
site during enterovirus infection. Cleavage in vitro was mediated by
3Cpro alone and was speciﬁc, because eIF1, eIF1A, eIF4B, eIF4F and eIF5
were not substrates for 3Cpro. The time course of eIF5B proteolysis
suggests that its cleavage could contribute to the shutoff of host and
viral translation observed in enterovirus-infected cells.
Results and discussion
Cleavage of eIF5B in enterovirus-infected cells
To determine whether the abundance or integrity of eIF5B was
altered during enterovirus infection, cytoplasmic lysates from polio-
virus type 1 (PV1) (Mahoney)- and Coxsackievirus B3 (CVB3)-infected
293T cells harvested at various times p.i. (Figs. 1A, B) were immu-
noblotted using polyclonal antibodies directed against the carboxy-
terminal amino acid residues 921–1220 of human eIF5B (Wilson et al.,
1999). A ~ 70kDa protein present in mock-infected cells that cross-
reacted with these antibodies is indicated by asterisks (Figs. 1C, D) and
served as an internal loading control. The origin of this and another
cross-reactive protein of ~ 110kDa (Fig. 1C) have not been established.A ~ 83kDa putative eIF5B cleavage product ﬁrst appeared at 3h p.i., a
time point that coincided with the initial appearance of viral proteins
(Figs. 1A, B), and subsequently increased in prominence. Cleavage of
eIF5B therefore begins early in enterovirus infection, at a similar time
to cleavage of eIF4G and PABP (Etchison et al., 1982; Gradi et al., 1998;
Kerekatte et al., 1999). Full length eIF5B with an apparent molecular
weight in these gel/buffer conditions of 175kDa (Pestova et al., 2000)
was readily detected by immunoblotting in lysates of 293T and HeLa
cells (Fig. 1 and data not shown), but its abundance during the course
of infection suggested that only partial cleavage of eIF5B had occurred.
The level of cleavage varied between experiments done with PV1 and
CVB3-infected 293T cells, in some instances being lower than shown
in Fig. 1, and did not correlate with the multiplicity of infection (data
not shown). The transient and variable appearance of additional
smaller immunoreactive bands in some infections (data not shown),
suggested that further cleavage or degradation of cleavage products
occurred in infected cells, possibly due to proteasome or caspase
activation, a characteristic of PV-infected cells (Belov et al., 2003;
Barral et al., 2007).
The observations that the level of eIF5B cleavage in enterovirus-
infected cells was variable suggested that eIF5B might under some
circumstances be protected from 3Cpro-mediated cleavage that we
reasoned might result either from post-transcriptional modiﬁcation,
such as phosphorylation (e.g. Beausoleil et al., 2004) or from inter-
action with other proteins. The kinases that phosphorylate eIF5B are
not known and phospho-speciﬁc eIF5B antibodies are not available, so
the inﬂuence of phosphorylation on eIF5B's susceptibility to cleavage
could not be characterized. eIF5B's interacting partners include eIF1A,
40S and 60S ribosomal subunits (Marintchev et al., 2003; Olsen et al.,
2003; Unbehaun et al., 2007), but their presence did not affect cleavage
of eIF5B byHRVor PV 3Cpro in vitro (data not shown). The reason for the
variable level of cleavage of eIF5B in infected cells therefore remains to
be determined.
Direct cleavage of eIF5B by enterovirus 3C protease
The analysis of virus-infected cell lysates suggested that entero-
viruses encode a protease that cleaved eIF5B, yielding at least one
fragment detectable by immunoblotting with antibodies directed
against its C-terminal region. Incubation with puriﬁed recombinant
HRV type14 (HRV14) 3Cpro resulted inpartial cleavage of puriﬁednative
rabbit eIF5B, yielding fragments (cp1 and cp2)with apparentmolecular
weights of ~ 85kDa and ~ 68kDa (Fig. 2A, lane 2). cp1was recognized by
mouse polyclonal antibodies directed against eIF5B1121–1219 (data not
shown). In similar experiments carried out with puriﬁed CVB3 3Cpro,
puriﬁednative eIF5Bwas also partially cleaved (Fig. 2C, lane 2),whereas
puriﬁed PV 3Cpro cleaved puriﬁed eIF5B to near-completion, in both
instances yielding cp1 and cp2 cleavage fragmentswith electrophoretic
mobilities like those of the HRV 3Cpro cleavage products (Fig. 2A, lanes 2
and 3). These cleavage reactions were performed overnight at 4°C, but
the speciﬁcity of cleavage was not changed on incubation for shorter
periods at 37°C (data not shown). We cannot rule out the possibility
that 3CDpro, themajor form of 3Cpro in infected cells (Ypma-Wong et al.,
1988) cleaves eIF5B with different kinetics than 3Cpro.
Cleavage of eIF5B by HRV14 and PV 3Cpro was speciﬁc, because
whereas a control substrate was cleaved to completion after incu-
bationwith HRV14 3Cpro (Fig. 2D, lane 2), the integrity and abundance
of puriﬁed recombinant eIF1, eIF1A, eIF4B and eIF5, and of puriﬁed
native eIF4F were unaltered after incubationwith HRV14 and PV 3Cpro
in identical conditions (Fig. 2A, lanes 5 and 6; Fig. 2B, lanes 2, 3, 5 and
6; Fig. 2D, lane 4; Fig. 2E, lane 4). A recombinant fragment of eIF5B
corresponding to amino acid residues 587–1220 (“eIFΔ5B”) was not
cleaved by HRV14 3Cpro in these conditions (Fig. 2E, lanes 1 and 2),
indicating that cleavage likely occurred upstream of a.a. 587. These
observations extend earlier reports that eIF2, eIF3, eIF4A, eIF4B and
eIF4E are not cleaved during enterovirus infections (Duncan et al.,
Fig. 2. Speciﬁc cleavage of eIF5B by CVB3, HRV14 and PV1 3C proteases. (A) Puriﬁed native rabbit eIF5B (lanes 1–3) and puriﬁed recombinant human eIF5 (lanes 4–6), (B) puriﬁed
recombinant human eIF1 (lanes 1–3) and puriﬁed recombinant human eIF1A (lanes 4–6), (C) puriﬁed native rabbit eIF5B (lanes 1–3), (D) control protease substrate (lanes 1 and 2)
and puriﬁed native rabbit eIF4F, and (E) puriﬁed recombinant human eIF5B587–1220 (eIFΔ5B) (lanes 1 and 2) and puriﬁed recombinant human eIF4B (lanes 3 and 4) were incubated
alone, with puriﬁed recombinant CVB3 3Cpro, HRV 14 3Cpro or PV1 3Cpro, as indicated. Reaction mixtures were then analyzed by SDS-polyacrylamide gel electrophoresis and
Coomassie staining. The positions of 3C proteases, of initiation factors and, in the case of eIF5B, of their cp1 and cp2 cleavage products on gels are indicated to the right of each panel.
The asterisk (⁎) indicates a contaminant co-purifying with recombinant eIF4B (c.f. Pisarev et al., 2007).
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1989).
To map the cleavage site precisely, the N-terminal sequence of the
cp1 fragment of native rabbit eIF5B was determined by Edman
sequencing to be [G/S]GQEK[E/S]DTPP. This peptide sequence aligns
precisely with the deduced sequence of a fragment of rabbit genomic
DNA (Fig. 3B) and aligns well with a single conserved region of human
eIF5B, which is consistent with cleavage of human eIF5B at Q478–
G479 (Fig. 3B). The molecular weight of the C-terminal cp1 cleavage
fragment of human eIF5B is 83.8 kDa, which is consistent with the
molecular weight of the cleavage fragment identiﬁed in enterovirus-Fig. 3. (A) Diagrammatic representation of human eIF5B. The site of cleavage by HRV14 3Cpr
structural domains (I–IV) (54). (B) CLUSTAL-W alignment of the N-terminal sequence of the
eIF5B coding sequence, deduced from an O. cuniculus genomic fragment (Genbank: AAGW0infected 293T cells and in in vitro reactions done using puriﬁed eIF5B
and CVB3, HRV14 and PV1 3C proteases (e.g. Figs. 1 and 2A, C). The
highly charged amino-terminal domain of eIF5B is responsible for its
anomalous mobility in SDS-PAGE (Wilson et al., 1999; Pestova et al.,
2000), and accordingly, the molecular weight of the N-terminal cp2
cleavage fragment of human eIF5B (55.1 kDa) is less than that
predicted on the basis of its mobility in SDS-PAGE (~68 kDa). Cleavage
at VVEQ↓G in rabbit eIF5B and likely at VMEQ↓G479 in human eIF5B is
consistent with the cleavage speciﬁcity of enterovirus 3C proteases,
for which the principal determinants for cleavage are Gln-Gly (Q–G)
amino acid pairs ﬂanking the scissile bond, and any of a small subset ofo is shown relative to the positively charged N-terminal domain and the four conserved
3Cpro cleavage product cp1 of rabbit (Oryctolagus cuniculus) eIF5B, the corresponding
1235144.1), and the sequence of human eIF5B (Genbank: NM_015904).
121S. de Breyne et al. / Virology 378 (2008) 118–122amino acids (usually Ala or Val, but also other amino acids with small,
aliphatic side chains) at the P4 position (Cordingley et al., 1990). It is
also consistent with the cleavage speciﬁcity of enterovirus 3C
proteases for cellular substrates such as TATA-binding protein, PABP,
and NF-κB (p65-RelA) in which the principal 3C cleavage sites are
ASPQ↓G (Das and Dasgupta,1993), VHVQ↓G (Kuyumcu-Martinez et al.,
2002), and LLNQ↓G (Neznanov et al., 2005), respectively. Despite the
structural homology of enteroviral 3C proteinases, sequence variation
between the three proteinases tested here (42%–59% pairwise amino
acid identity) includes residues that determine substrate speciﬁcity at
P2 and P2′ positions relative to the scissile bond (Matthews et al.,
1999; Binford et al., 2005; Lee et al., 2007). These differences may
account for the different extents of cleavage observed here.
The large amino-terminal domain (NTD) that is cleaved from
mammalian eIF5B by 3Cpro does not signiﬁcantly inﬂuence nucleotide
binding by this factor (Pisareva et al., 2007), but the kinetics of other
individual steps in theworking cycle of mammalian eIF5B have not yet
been characterized. eIF5B is one of the least abundant initiation factors
(Pisarev et al., 2007), so that any change in its activity caused by
proteolytic cleavage might therefore contribute to enterovirus-in-
duced shutoff of translation. There are several indications how eIF5B's
activity might be altered by 3Cpro-mediated cleavage, which separates
the N-terminal domain of eIF5B from its essential conserved central
GTPase and C-terminal domains. First, the GTP-dependency of the
activity of eIF5B in ribosomal subunit joining is altered in some
circumstances bydeletion of anN-terminal fragment fromeIF5B that is
similar in size to that cleaved off by 3Cpro (Pestova et al., 2000). Second,
the NTD of yeast eIF5B binds directly to eIF1A (Olsen et al., 2003), a
component of 43S complexes that binds directly to the 40S subunit, so
that deletion of the eIF5B NTD might affect the kinetics of binding of
eIF5B to 48S complexes or of its release fromassembled 80S ribosomes.
Third, by analogy with the corresponding domain in eIF5B's prokar-
yotic homologue IF2, which is required for maximal growth, the NTD
could interact with or induce conformational changes in the small
ribosomal subunit (Moreno et al., 1999; Caserta et al., 2006).
In summary, these studies have identiﬁed eIF5B as a novel
enterovirus 3Cpro substrate, and the time course of eIF5B proteolysis
in infected cells suggests that it could contribute to the virus-induced
shutoff of host and viral translation. 3Cpro impairs cap-mediated
initiation (Kuyumcu-Martinez et al., 2004) and initiation mediated by
PV1 and CVB3 IRESs (our unpublished data). Future studies will be
directed to identifying the contribution of eIF5B cleavage to shutoff
relative to the effects of 3Cpro-mediated cleavage of other factors
involved in enterovirus translation, such as PABP and the IRES trans-
acting factors PTB and PCBP2 (Back et al., 2002; Perera et al., 2007).
Methods
Cells and virus infection
293T cells were cultured in Dulbecco's Modiﬁed Eagle Medium
(DMEM) supplemented with glutamine and 10% fetal bovine serum
(FBS). Poliovirus (Type 1, Mahoney) and Coxsackievirus B3 were grown
in HeLa cells and puriﬁed on cesium chloride gradients (Jones and
Ehrenfeld, 1983) and from infected HeLa supernatants by polyethylene
glycol precipitation (Kuyumcu-Martinez et al., 2002), respectively. 293T
cells orHeLa cellswere infectedwith PV1atMOI=30or CVB3atMOI=10
in serum-freeDMEM.At 1hour post-infection,mediawere removedand
replacedwithDMEMcontaining2% FBS.Metabolic labelingwas done by
incubating cells for 1h in (–met,–cys)DMEMcontaining2%dialyzed FBS
and 35S-Trans label (MP Biomedicals) at 30 μCi/mL.
Puriﬁcation of ribosomal subunits and eukaryotic initiation factors
Native eIF4F and eIF5B were puriﬁed from rabbit reticulocyte
lysate (Pisarev et al., 2007). Recombinant eIF1, eIF1A, eIF4B, eIF5 andeIF5B587–1220 (eIFΔ5B) were overexpressed in Escherichia coli and
puriﬁed (Pisarev et al., 2007). The integrity and activity of these factors
and ribosomal subunits were assessed by polyacrylamide gel electro-
phoresis and using functional assays dependent on each of them
(Pisarev et al., 2007).
eIF5B cleavage assays, sequencing, and blotting
Recombinant PV 3Cpro and CVB3 3Cpro were expressed in E. coli
and puriﬁed as described (Joachims et al., 1999; Zell et al., 2002);
recombinant HRV14 3Cpro was from Novagen (Madison, WI). To assay
cleavage of individual initiation factors, 2 μg eIF5B, eIFΔ5B, eIF1,
eIF1A, eIF5, eIF4B or eIF4F was incubated overnight at 4 °C in cleavage
buffer (150 mM NaCl, 50 mM Tris HCl pH 7.5) and with 1 μg HRV
3Cpro, 1 μg CVB3 3Cpro, 0.5 μg PV 3Cpro or without added protease.
Cleavage products were analyzed by SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE); gels were stained with Coomassie blue.
Immunoblotting of eIF5B and its cleavage products was done using
polyclonal rabbit antibodies directed against amino acid residues
921–1220 of human eIF5B (Wilson et al., 1999) or polyclonal mouse
antibodies directed against amino acid residues 1121–1219 of human
eIF5B (Abnova). The eIF5B cp1 cleavage product was resolved by SDS-
PAGE and transferred to PVDF membrane for amino-terminal
sequencing.
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